Literature DB >> 7744702

Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.

H Kobayashi1, H Sakahara, K Endo, M Hosono, Z S Yao, S Toyama, J Konishi.   

Abstract

Injection of avidin can decrease the background radioactivity due to a radiolabeled biotinylated monoclonal antibody. We compared the chase effects of avidin, streptavidin, neutravidin, and avidin-conjugated ferritin on a radiolabeled antitumor monoclonal antibody in tumor-bearing nude mice. A radioiodine-labeled biotinylated monoclonal antibody (OST7) was administered to athymic mice bearing osteogenic sarcomas. After 24 h, an avidin, streptavidin, neutravidin or avidin-conjugated ferritin chaser was intravenously injected into the mice. At 2 h after the chase, the biodistribution of the radiolabeled monoclonal antibody was determined. Clearance from the blood was dose-dependently accelerated by avidin and its effect was 10-fold stronger than that of neutravidin or avidin-ferritin. Streptavidin did not promote clearance of the biotinylated antibody. Avidin was the most effective chasing agent for improving the biodistribution of the radiolabeled biotinylated monoclonal antibody among the four avidin derivatives tested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744702      PMCID: PMC5920811          DOI: 10.1111/j.1349-7006.1995.tb03056.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  New methods for localizing infection: a role for avidin-biotin?

Authors:  D A Goodwin
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

2.  A SPECTROPHOTOMETRIC ASSAY FOR AVIDIN AND BIOTIN BASED ON BINDING OF DYES BY AVIDIN.

Authors:  N M GREEN
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  A new method for faster blood clearance in radioimmuno-guided surgery.

Authors:  G Paganelli; M Stella; P De Nardi; P Magnani; F Zito; A G Siccardi; V Di Carlo; F Fazio
Journal:  J Nucl Biol Med       Date:  1991 Apr-Jun

5.  Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies.

Authors:  A L Klibanov; A V Martynov; M A Slinkin; M D Smirnov; V R Muzykantov; S M Danilov; V P Torchilin
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

6.  Rapid blood clearance of biotinylated IgG after infusion of avidin.

Authors:  V V Sinitsyn; A G Mamontova; Y Y Checkneva; A A Shnyra; S P Domogatsky
Journal:  J Nucl Med       Date:  1989-01       Impact factor: 10.057

7.  Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.

Authors:  D A Goodwin; C F Meares; M J McCall; M McTigue; W Chaovapong
Journal:  J Nucl Med       Date:  1988-02       Impact factor: 10.057

8.  Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies.

Authors:  G Paganelli; S Pervez; A G Siccardi; G Rowlinson; G Deleide; F Chiolerio; M Malcovati; G A Scassellati; A A Epenetos
Journal:  Int J Cancer       Date:  1990-06-15       Impact factor: 7.396

9.  Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.

Authors:  G Paganelli; P Magnani; F Zito; E Villa; F Sudati; L Lopalco; C Rossetti; M Malcovati; F Chiolerio; E Seccamani
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

10.  Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.

Authors:  H Sakahara; K Endo; T Nakashima; M Koizumi; M Kunimatsu; Y Kawamura; H Ohta; T Nakamura; H Tanaka; Y Kotoura
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

View more
  5 in total

Review 1.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal:  Chem Soc Rev       Date:  2011-05-23       Impact factor: 54.564

2.  Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration.

Authors:  Dafeng Chu; Xinyue Dong; Qi Zhao; Jingkai Gu; Zhenjia Wang
Journal:  Adv Mater       Date:  2017-05-15       Impact factor: 30.849

3.  PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.

Authors:  Nicole Cauchon; Réjean Langlois; Jacques A Rousseau; Guillaume Tessier; Jules Cadorette; Roger Lecomte; Darel J Hunting; Roberto A Pavan; Stefan K Zeisler; Johan E van Lier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

4.  Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

5.  Intracellular in situ labeling of TiO2 nanoparticles for fluorescence microscopy detection.

Authors:  Koshonna Brown; Ted Thurn; Lun Xin; William Liu; Remon Bazak; Si Chen; Barry Lai; Stefan Vogt; Chris Jacobsen; Tatjana Paunesku; Gayle E Woloschak
Journal:  Nano Res       Date:  2017-07-19       Impact factor: 8.897

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.